🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 7 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/05/1998 42,75 42,75 40,50 40,50 -5,26% 5,26% 3.733
01/05/1998 42,75 42,75 41,63 42,75 -1,30% 2,63% 3.067
30/04/1998 44,63 44,63 43,13 43,31 +0,43% 3,36% 1.033
29/04/1998 43,13 43,88 42,75 43,13 +1,77% 2,61% 5.917
28/04/1998 41,63 42,38 41,25 42,38 +1,80% 2,70% 1.433
27/04/1998 42,75 42,75 39,75 41,63 -0,89% 7,02% 7.400
24/04/1998 42,75 43,13 41,63 42,00 +0,90% 3,51% 5.517
23/04/1998 42,75 44,25 41,63 41,63 -5,93% 6,14% 8.867
22/04/1998 45,00 45,00 42,75 44,25 +0,00% 5,00% 3.017
21/04/1998 45,00 45,75 42,75 44,25 -1,67% 6,67% 9.433
20/04/1998 43,88 45,00 43,13 45,00 +4,35% 4,27% 7.250
17/04/1998 42,75 48,00 42,00 43,13 +2,68% 14,04% 24.417
16/04/1998 41,25 42,00 40,88 42,00 +5,66% 2,73% 7.767
15/04/1998 39,75 41,25 39,00 39,75 +1,92% 5,66% 1.267
14/04/1998 39,75 40,88 39,00 39,00 -1,89% 4,72% 2.350
13/04/1998 41,25 41,63 39,38 39,75 -3,64% 5,45% 2.783
09/04/1998 41,63 41,63 39,75 41,25 +4,76% 4,50% 1.150
08/04/1998 42,00 42,00 39,38 39,38 -6,25% 6,25% 2.550
07/04/1998 42,00 42,38 41,25 42,00 +3,70% 2,68% 3.567
06/04/1998 42,75 42,75 39,00 40,50 -4,42% 8,77% 4.583
03/04/1998 43,13 44,25 42,38 42,38 -1,74% 4,35% 5.850
02/04/1998 43,50 45,00 42,75 43,13 -2,54% 5,17% 6.200
01/04/1998 42,75 44,25 42,00 44,25 +3,51% 5,26% 6.167
31/03/1998 40,88 42,75 39,38 42,75 +3,64% 8,26% 6.750
30/03/1998 43,50 43,50 40,13 41,25 -1,35% 7,76% 5.617
27/03/1998 44,25 45,00 41,81 41,81 -4,70% 7,20% 7.967
26/03/1998 40,88 45,00 40,50 43,88 +7,34% 11,01% 31.183
25/03/1998 42,00 42,00 39,38 40,88 -0,91% 6,25% 7.900
24/03/1998 41,25 41,63 39,75 41,25 +0,00% 4,55% 6.633
23/03/1998 40,88 42,75 39,75 41,25 +0,92% 7,34% 11.017